Research statistics
BAM15 research: publications and trials
At a glance
Publications, all years
60
Since 2013
Publications in 2026 so far
10
Through November 15, 2026
Human clinical research
0.0%
0 of 60 classified
Registered clinical trials
0
ClinicalTrials.gov
Randomized controlled trials
0
Publications reporting an RCT in people
Systematic reviews and meta-analyses
0
Preclinical studies
95.0%
43 animal · 14 in vitro · 0 computational
Records that only mention it
14
Not counted above
Status in the library: Research only.
What to keep in mind
- No human clinical publication is indexed: everything published so far is preclinical, a review or commentary.
- Fewer than three randomized controlled trials are indexed.
- More than 70% of the indexed publications are animal, cell or computational studies.
- Not a peptide: it is shown for completeness and left out of every peptide total.
Publications by year
BAM15 publications by year and evidence
Show the data
| Year | Preclinical (animal, in vitro, computational) | Reviews and meta-analyses | Other and not yet classified | Total |
|---|---|---|---|---|
| 2013 | 1 | 0 | 0 | 1 |
| 2015 | 2 | 0 | 0 | 2 |
| 2018 | 3 | 0 | 0 | 3 |
| 2019 | 1 | 0 | 0 | 1 |
| 2020 | 6 | 0 | 0 | 6 |
| 2021 | 3 | 0 | 0 | 3 |
| 2022 | 8 | 0 | 0 | 8 |
| 2023 | 7 | 1 | 0 | 8 |
| 2024 | 10 | 0 | 0 | 10 |
| 2025 | 7 | 1 | 0 | 8 |
| 2026 (to date) | 9 | 0 | 1 | 10 |
Study types
| Animal study | 43 |
|---|---|
| In vitro study | 14 |
| Review | 2 |
| Editorial, letter or other | 1 |
Research areas
From MeSH major topics. A paper can be in several areas.
| Metabolic health | 23 |
|---|---|
| Obesity and weight management | 11 |
| Oncology | 11 |
| Neurological and mental health | 10 |
| Immune system | 8 |
| Cardiovascular | 7 |
| Gastrointestinal | 7 |
| Antimicrobial and infectious disease | 5 |
| Longevity and aging | 5 |
| Reproductive and sexual health | 3 |
| Tissue repair | 3 |
| Cognitive health | 2 |
Registered clinical trials
A registration is not a result.
No registered trials.
Human trials and evidence reviews
Meta-analyses, systematic reviews and trials in people, newest first.
No human trial, systematic review or meta-analysis of BAM15 is indexed.
Most cited
By OpenAlex citation count. Citations measure attention, not quality or correctness.
- Identification of a novel mitochondrial uncoupler that does not depolarize the plasma membrane.
Molecular metabolism · November 28, 2013 · In vitro study · cited 243 times · open access
PMID 24634817 · DOI 10.1016/j.molmet.2013.11.005 · In vitro studies
- Mitochondrial uncoupler BAM15 reverses diet-induced obesity and insulin resistance in mice.
Nature communications · May 14, 2020 · Animal study · cited 136 times · open access
PMID 32409697 · DOI 10.1038/s41467-020-16298-2 · Animal studies
- Quantification of Oxygen Consumption in Retina Ex Vivo Demonstrates Limited Reserve Capacity of Photoreceptor Mitochondria.
Investigative ophthalmology & visual science · December 1, 2015 · Animal study · cited 126 times · open access
PMID 26747773 · DOI 10.1167/iovs.15-17901 · Animal studies
- BAM15-mediated mitochondrial uncoupling protects against obesity and improves glycemic control.
EMBO molecular medicine · June 10, 2020 · Animal study · cited 90 times · open access
PMID 32519812 · DOI 10.15252/emmm.202012088 · Animal studies
- Mitochondrial uncoupling attenuates sarcopenic obesity by enhancing skeletal muscle mitophagy and quality control.
Journal of cachexia, sarcopenia and muscle · March 19, 2022 · Animal study · cited 82 times · open access
PMID 35304976 · DOI 10.1002/jcsm.12982 · Animal studies
Latest publications
- BAM15-mediated mitochondrial uncoupling modulates cold-stress resilience through redox and genome-maintenance responses.
Free radical biology & medicine · November 12, 2026 · Animal study · cited 0 times
PMID 43020441 · DOI 10.1016/j.freeradbiomed.2026.11.024 · Animal studies
- BAM15 improves oocyte quality against obesity via PPARγ-dependent mitochondrial function.
Protein & cell · November 1, 2026 · Editorial, letter or other · cited 0 times · open access
PMID 42178393 · DOI 10.1093/procel/pwag035 · Commentary and other
- BAM15 Enhances Regorafenib Cytotoxicity in a Canine Osteosarcoma Cell Model.
International journal of molecular sciences · October 14, 2026 · Animal study · cited 0 times · open access
PMID 42941891 · DOI 10.3390/ijms27209121 · Animal studies
- Mitochondrial uncoupler BAM15 attenuates cryopreservation-induced damage in human sperm by stabilizing mitochondrial homeostasis†.
Biology of reproduction · September 1, 2026 · In vitro study · cited 0 times
PMID 42295994 · DOI 10.1093/biolre/ioag123 · In vitro studies
- A Programmed Drug-Loaded and Penetration-Delivery Functionalized Microneedle Patch for Synergistic Obesity Treatment.
Advanced healthcare materials · July 6, 2026 · Animal study · cited 0 times · open access
PMID 42403298 · DOI 10.1002/adhm.71409 · Animal studies
- Mitochondrial uncoupling inhibits serine catabolism <i>via</i> FTO activation in metastatic breast cancer.
Cancer biology & medicine · March 1, 2026 · Animal study · cited 3 times · open access
PMID 41821182 · DOI 10.20892/j.issn.2095-3941.2025.0444 · Animal studies
- Structure-activity relationship profiling of N-substituted 8-trifluoromethyl-9H-purin-6-amines as mitochondrial protonophores.
European journal of medicinal chemistry · February 18, 2026 · Animal study · cited 0 times · open access
PMID 41734593 · DOI 10.1016/j.ejmech.2026.118694 · Animal studies
- BAM 15 Exerts Molluscicidal Effects on <i>Pomacea canaliculata</i> Through the Induction of Oxidative Stress, Impaired Energy Metabolism, and Tissue Damage.
Molecules (Basel, Switzerland) · January 20, 2026 · Animal study · cited 0 times · open access
PMID 41599409 · DOI 10.3390/molecules31020361 · Animal studies
- Mitochondrial uncoupler BAM15 ameliorates liver lipid metabolism disorders by activating the AMPK pathway.
The FEBS journal · January 12, 2026 · Animal study · cited 0 times
PMID 41527408 · DOI 10.1111/febs.70400 · Animal studies
- FUNDC1-Associated Regulation of Mitochondrial Function Is Crucial for Preventing Endothelial Injury in Hyperglycemia.
Oxidative medicine and cellular longevity · January 1, 2026 · In vitro study · cited 0 times · open access
PMID 42267664 · DOI 10.1155/omcl/6619225 · In vitro studies
How this is counted
PubMed records matched by the names below, counted when the peptide is in the title, indexed by MeSH, or confirmed from the abstract. The exact query can be rerun on Europe PMC. Methodology
Search terms: BAM15; N5,N6-bis(2-fluorophenyl)[1,2,5]oxadiazolo[3,4-b]pyrazine-5,6-diamine
((TITLE_ABS:"BAM15" OR CHEM:"BAM15" OR TITLE_ABS:"BAM 15" OR CHEM:"BAM 15") OR (TITLE_ABS:"N5,N6-bis(2-fluorophenyl)[1,2,5]oxadiazolo[3,4-b]pyrazine-5,6-diamine" OR CHEM:"N5,N6-bis(2-fluorophenyl)[1,2,5]oxadiazolo[3,4-b]pyrazine-5,6-diamine" OR TITLE_ABS:"N5,N6-bis(2-fluorophenyl)[1,2,5]oxadiazolo[3,4-b]pyrazine5,6-diamine" OR CHEM:"N5,N6-bis(2-fluorophenyl)[1,2,5]oxadiazolo[3,4-b]pyrazine5,6-diamine" OR TITLE_ABS:"N 5,N 6-bis(2-fluorophenyl)[1,2,5]oxadiazolo[3,4-b]pyrazine-5,6-diamine" OR CHEM:"N 5,N 6-bis(2-fluorophenyl)[1,2,5]oxadiazolo[3,4-b]pyrazine-5,6-diamine")) AND SRC:MED
Cite this page
Peptide Library. (2026, November 16). BAM15 research statistics (Version weekly-2026-11-15) [Statistic]. Peptide Library. https://peptidelibrary.app/research/peptides/bam15